跳至主要内容
临床试验/NCT01929161
NCT01929161已完成1 期

Affective and Genomic Mediators of Sustained Behavior Change: A Randomized, Dual-blind, Placebo-controlled Experimental Design That Will Examine Wellness Behavior as a Function of Oxytocin vs. Placebo.

University of North Carolina, Chapel Hill1 个研究点 分布在 1 个国家目标入组 239 人开始时间: 2013年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
239
试验地点
1
主要终点
Change in nonconscious incentive salience (as measured by the Affect Misattribution Procedure).

研究概览

简要总结

The specific aim of this study is to test whether oxytocin (OT) boosts the positive emotion yield of a new wellness behavior (Lovingkindness meditation or Mindfulness meditation) and thereby increases nonconscious motives that shape daily behavioral decisions to repeat it, which in turn foster positive emotions that further augment nonconscious motives in an upward spiral dynamic.

The proposed research targets three hypotheses: (1) Oxytocin manipulation magnifies (i.e., moderates) the positive emotion yield of Lovingkindness meditation; (2) The positive emotion yield of meditation, which varies by experimental condition, increases the nonconscious incentive salience of Wellness Behavior-related cues; and (3) Behavioral decisions predict positive emotions, sparking the relationships among OT manipulation, positive emotion yield, and nonconscious incentive salience of Wellness Behavior-related cues.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
35 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • between the ages of 35 and 64 years old.
  • Fluent in written and spoken English
  • Willingness or interest in learning to meditate
  • Computer literate with access to internet (weekly)

排除标准

  • Women who are pregnant or breastfeeding
  • Individuals on antihypertensive medication
  • Individuals who have or have had a regular meditation practice
  • Individuals who can read Chinese logographs

研究组 & 干预措施

Oxytocin

Experimental

Oxytocin intranasal spray, 6 intranasal sufflations which deliver a total of 24 international units of oxytocin

干预措施: Oxytocin (Drug)

Oxytocin

Experimental

Oxytocin intranasal spray, 6 intranasal sufflations which deliver a total of 24 international units of oxytocin

干预措施: Lovingkindness Meditation (Behavioral)

Oxytocin

Experimental

Oxytocin intranasal spray, 6 intranasal sufflations which deliver a total of 24 international units of oxytocin

干预措施: Mindfulness Meditation (Behavioral)

Placebo (for oxytocin)

Placebo Comparator

Intranasal spray with all equivalent ingredients except oxytocin

干预措施: Placebo (for oxytocin) (Drug)

Placebo (for oxytocin)

Placebo Comparator

Intranasal spray with all equivalent ingredients except oxytocin

干预措施: Lovingkindness Meditation (Behavioral)

Placebo (for oxytocin)

Placebo Comparator

Intranasal spray with all equivalent ingredients except oxytocin

干预措施: Mindfulness Meditation (Behavioral)

Lovingkindness Meditation

Experimental

Lovingkindness guided meditation experienced in the laboratory and 6 additional LKM meditations taken home on the iPod.

干预措施: Oxytocin (Drug)

Lovingkindness Meditation

Experimental

Lovingkindness guided meditation experienced in the laboratory and 6 additional LKM meditations taken home on the iPod.

干预措施: Placebo (for oxytocin) (Drug)

Lovingkindness Meditation

Experimental

Lovingkindness guided meditation experienced in the laboratory and 6 additional LKM meditations taken home on the iPod.

干预措施: Lovingkindness Meditation (Behavioral)

Mindfulness Meditation

Placebo Comparator

Mindfulness guided meditation experienced in the laboratory and 6 additional Mindfulness meditations taken home on the iPod.

干预措施: Oxytocin (Drug)

Mindfulness Meditation

Placebo Comparator

Mindfulness guided meditation experienced in the laboratory and 6 additional Mindfulness meditations taken home on the iPod.

干预措施: Placebo (for oxytocin) (Drug)

Mindfulness Meditation

Placebo Comparator

Mindfulness guided meditation experienced in the laboratory and 6 additional Mindfulness meditations taken home on the iPod.

干预措施: Mindfulness Meditation (Behavioral)

结局指标

主要结局

Change in nonconscious incentive salience (as measured by the Affect Misattribution Procedure).

时间窗: Baseline and Weeks 1, 2, and 3

Affect Misattribution Procedure (AMP) - This measure of nonconscious incentive salience has acceptable internal consistency for an indirect measure of affect (.69 - .90) and has been found to predict judgments and behavioral outcomes above and beyond self-report measures.

Changes in meditation time

时间窗: Weeks 1, 2, and 3

Self-reported meditation time recorded daily and weekly. In addition, meditation track play times will be recorded from the iPod.

Change in positive emotions (as measured by the Modified Daily Emotions Scale)

时间窗: Baseline and Weeks 1, 2, and 3

Modified Daily Emotions Scale (mDES) - This measure of explicit positive affect has been successfully used by the PI in multiple studies to detect changes in positive emotion. Previous work by the PI found that Cronbach's alpha coefficient for the mDES positive emotion composite variable was 0.93 in sample of mid-life community adults similar to those anticipated for this study.

次要结局

  • Cardiac Vagal Tone(Baseline)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Barbara L. Fredrickson, PhD

Kenan Distinguished Professor

University of North Carolina, Chapel Hill

研究点 (1)

Loading locations...

相似试验

Study of Wellness Behaviors as a Function of... | 临床试验